Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fruquintinib Maintenance for Colorectal Cancer Liver Metastases After NED
NCT06018714Phase 2Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- May 2023
- Primary completion
- Aug 2024
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of fruquintinib in colorectal cancer (CRC), sponsored by Sun Yat-sen University. Started May 2023; status: recruiting.
02
Drugs
fruquintinib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT06018714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06018714.